Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 31 | 2025 | 56 | 9.740 |
Why?
|
| Bariatric Surgery | 27 | 2025 | 43 | 8.960 |
Why?
|
| Laparoscopy | 14 | 2019 | 146 | 3.700 |
Why?
|
| Gastric Bypass | 9 | 2023 | 18 | 3.140 |
Why?
|
| Gastrectomy | 12 | 2022 | 20 | 3.070 |
Why?
|
| Postoperative Complications | 21 | 2022 | 613 | 2.320 |
Why?
|
| Patient Discharge | 5 | 2025 | 103 | 2.140 |
Why?
|
| Middle Aged | 47 | 2025 | 7164 | 1.630 |
Why?
|
| Herniorrhaphy | 3 | 2018 | 17 | 1.560 |
Why?
|
| Male | 56 | 2025 | 13510 | 1.510 |
Why?
|
| Humans | 75 | 2025 | 28166 | 1.430 |
Why?
|
| Wounds and Injuries | 3 | 2025 | 185 | 1.410 |
Why?
|
| Female | 55 | 2025 | 15191 | 1.360 |
Why?
|
| Adult | 39 | 2025 | 7765 | 1.300 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2016 | 20 | 1.250 |
Why?
|
| Retrospective Studies | 23 | 2025 | 2558 | 1.190 |
Why?
|
| Registries | 3 | 2020 | 386 | 1.190 |
Why?
|
| Preoperative Care | 3 | 2025 | 82 | 1.180 |
Why?
|
| Obesity | 7 | 2022 | 668 | 1.160 |
Why?
|
| Hernia, Ventral | 2 | 2018 | 11 | 1.140 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 50 | 1.090 |
Why?
|
| Weight Loss | 7 | 2025 | 81 | 0.990 |
Why?
|
| Patient Readmission | 6 | 2019 | 103 | 0.920 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 108 | 0.900 |
Why?
|
| Quality Improvement | 5 | 2022 | 115 | 0.850 |
Why?
|
| Trauma Centers | 2 | 2025 | 119 | 0.850 |
Why?
|
| Tissue Adhesives | 2 | 2015 | 5 | 0.850 |
Why?
|
| Anastomotic Leak | 4 | 2017 | 9 | 0.840 |
Why?
|
| Treatment Outcome | 16 | 2025 | 2383 | 0.840 |
Why?
|
| Laparotomy | 2 | 2013 | 30 | 0.790 |
Why?
|
| Mammaplasty | 1 | 2022 | 12 | 0.790 |
Why?
|
| Venous Thromboembolism | 4 | 2022 | 133 | 0.790 |
Why?
|
| United States | 15 | 2023 | 2151 | 0.780 |
Why?
|
| Length of Stay | 11 | 2025 | 232 | 0.780 |
Why?
|
| Aged | 18 | 2025 | 5416 | 0.770 |
Why?
|
| Sutures | 2 | 2012 | 15 | 0.750 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 367 | 0.740 |
Why?
|
| Patient Transfer | 2 | 2018 | 43 | 0.730 |
Why?
|
| Risk Factors | 14 | 2024 | 2087 | 0.720 |
Why?
|
| Gastroplasty | 3 | 2019 | 5 | 0.710 |
Why?
|
| Robotic Surgical Procedures | 2 | 2018 | 45 | 0.700 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 215 | 0.690 |
Why?
|
| Heart Injuries | 1 | 2020 | 8 | 0.660 |
Why?
|
| Wounds, Penetrating | 1 | 2020 | 25 | 0.660 |
Why?
|
| Forecasting | 1 | 2020 | 75 | 0.640 |
Why?
|
| Aorta, Abdominal | 1 | 2019 | 15 | 0.620 |
Why?
|
| Body Mass Index | 6 | 2025 | 398 | 0.620 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2019 | 24 | 0.620 |
Why?
|
| Elective Surgical Procedures | 2 | 2018 | 70 | 0.610 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 477 | 0.600 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 54 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 330 | 0.570 |
Why?
|
| Models, Statistical | 1 | 2018 | 128 | 0.570 |
Why?
|
| Accidental Falls | 1 | 2018 | 32 | 0.570 |
Why?
|
| Prospective Studies | 9 | 2017 | 1257 | 0.540 |
Why?
|
| Operative Time | 6 | 2016 | 41 | 0.540 |
Why?
|
| Injury Severity Score | 3 | 2025 | 121 | 0.540 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 464 | 0.540 |
Why?
|
| Hemorrhoidectomy | 1 | 2016 | 2 | 0.530 |
Why?
|
| Hemorrhoids | 1 | 2016 | 3 | 0.530 |
Why?
|
| Laser Coagulation | 1 | 2016 | 13 | 0.530 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 20 | 0.510 |
Why?
|
| Pancreatitis | 1 | 2016 | 39 | 0.510 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2016 | 4 | 0.510 |
Why?
|
| Pain, Postoperative | 2 | 2013 | 62 | 0.490 |
Why?
|
| Program Evaluation | 1 | 2016 | 167 | 0.490 |
Why?
|
| Stress, Physiological | 1 | 2016 | 96 | 0.470 |
Why?
|
| Students, Medical | 1 | 2016 | 97 | 0.470 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2014 | 3 | 0.460 |
Why?
|
| Echinococcosis | 1 | 2014 | 2 | 0.460 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 23 | 0.440 |
Why?
|
| Hernia, Hiatal | 1 | 2013 | 4 | 0.430 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 41 | 0.420 |
Why?
|
| Databases, Factual | 8 | 2018 | 255 | 0.420 |
Why?
|
| Oklahoma | 3 | 2025 | 1005 | 0.420 |
Why?
|
| Bupivacaine | 1 | 2013 | 4 | 0.410 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2013 | 5 | 0.410 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 11 | 0.410 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 9 | 0.410 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 12 | 0.410 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 84 | 0.410 |
Why?
|
| Sarcoma | 1 | 2013 | 29 | 0.400 |
Why?
|
| Acanthosis Nigricans | 1 | 2012 | 4 | 0.390 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 16 | 0.390 |
Why?
|
| Anticoagulants | 2 | 2021 | 294 | 0.380 |
Why?
|
| Hospital Mortality | 4 | 2020 | 149 | 0.380 |
Why?
|
| Postoperative Care | 3 | 2017 | 68 | 0.360 |
Why?
|
| Anastomosis, Surgical | 1 | 2011 | 37 | 0.360 |
Why?
|
| Blood Vessels | 1 | 2011 | 59 | 0.340 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 148 | 0.340 |
Why?
|
| Glucocorticoids | 3 | 2016 | 115 | 0.340 |
Why?
|
| Stents | 1 | 2011 | 121 | 0.340 |
Why?
|
| Adolescent | 6 | 2019 | 3128 | 0.320 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 32 | 0.300 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 33 | 0.300 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 54 | 0.290 |
Why?
|
| Patient Safety | 3 | 2019 | 38 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 107 | 0.280 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 969 | 0.270 |
Why?
|
| Algorithms | 1 | 2009 | 433 | 0.250 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2017 | 18 | 0.250 |
Why?
|
| Renal Dialysis | 2 | 2016 | 52 | 0.240 |
Why?
|
| Anti-Obesity Agents | 1 | 2025 | 4 | 0.240 |
Why?
|
| Sepsis | 2 | 2020 | 84 | 0.230 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 302 | 0.230 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2021 | 0.230 |
Why?
|
| Young Adult | 5 | 2019 | 2738 | 0.220 |
Why?
|
| Hospitalization | 3 | 2024 | 202 | 0.220 |
Why?
|
| Comorbidity | 3 | 2019 | 257 | 0.210 |
Why?
|
| Prognosis | 3 | 2016 | 803 | 0.210 |
Why?
|
| African Americans | 2 | 2015 | 350 | 0.200 |
Why?
|
| Splenectomy | 2 | 2015 | 44 | 0.200 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 112 | 0.190 |
Why?
|
| Stroke Volume | 1 | 2022 | 123 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 98 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 70 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2017 | 889 | 0.180 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 126 | 0.180 |
Why?
|
| Survival Rate | 2 | 2020 | 430 | 0.180 |
Why?
|
| Esophagectomy | 2 | 2011 | 9 | 0.180 |
Why?
|
| China | 1 | 2021 | 61 | 0.180 |
Why?
|
| Diabetic Foot | 2 | 2013 | 17 | 0.170 |
Why?
|
| Limb Salvage | 2 | 2013 | 21 | 0.170 |
Why?
|
| Incidence | 2 | 2020 | 562 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 775 | 0.170 |
Why?
|
| Esophageal Neoplasms | 2 | 2011 | 32 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 386 | 0.170 |
Why?
|
| Adiposity | 1 | 2021 | 94 | 0.170 |
Why?
|
| Reoperation | 2 | 2019 | 145 | 0.170 |
Why?
|
| Prevalence | 2 | 2019 | 494 | 0.160 |
Why?
|
| Medicine | 1 | 2019 | 22 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1015 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2018 | 611 | 0.160 |
Why?
|
| Direct Service Costs | 1 | 2018 | 1 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 40 | 0.150 |
Why?
|
| Hypertension | 3 | 2016 | 309 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 62 | 0.150 |
Why?
|
| Personnel Turnover | 1 | 2018 | 11 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2020 | 724 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2018 | 24 | 0.150 |
Why?
|
| Creatinine | 2 | 2015 | 59 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 37 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2018 | 311 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2018 | 289 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 29 | 0.140 |
Why?
|
| Gastric Fistula | 1 | 2017 | 1 | 0.140 |
Why?
|
| Double-Blind Method | 2 | 2016 | 417 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 78 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 105 | 0.140 |
Why?
|
| Physicians | 1 | 2018 | 82 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2017 | 29 | 0.140 |
Why?
|
| Age Distribution | 1 | 2017 | 73 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2017 | 78 | 0.130 |
Why?
|
| Actinomycosis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Back Pain | 1 | 2016 | 20 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 50 | 0.130 |
Why?
|
| Feedback | 1 | 2016 | 33 | 0.130 |
Why?
|
| Hernia, Inguinal | 1 | 2016 | 6 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 63 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 70 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 39 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 346 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2019 | 241 | 0.130 |
Why?
|
| Spinal Fractures | 1 | 2016 | 41 | 0.130 |
Why?
|
| Heart Failure | 1 | 2019 | 247 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 969 | 0.130 |
Why?
|
| Epinephrine | 1 | 2016 | 38 | 0.130 |
Why?
|
| Cholecystectomy | 1 | 2016 | 15 | 0.130 |
Why?
|
| Abdomen | 1 | 2016 | 42 | 0.120 |
Why?
|
| Propensity Score | 3 | 2024 | 55 | 0.120 |
Why?
|
| Smoking | 2 | 2017 | 473 | 0.120 |
Why?
|
| Stroke | 1 | 2019 | 252 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 92 | 0.120 |
Why?
|
| Stomach | 1 | 2015 | 43 | 0.120 |
Why?
|
| Pressure | 1 | 2016 | 90 | 0.120 |
Why?
|
| Serum Albumin | 1 | 2015 | 35 | 0.120 |
Why?
|
| Steroids | 1 | 2016 | 55 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2016 | 89 | 0.120 |
Why?
|
| Florida | 1 | 2015 | 54 | 0.120 |
Why?
|
| Blood Coagulation Disorders | 1 | 2015 | 26 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2016 | 194 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 69 | 0.120 |
Why?
|
| Health Status | 1 | 2016 | 148 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 300 | 0.120 |
Why?
|
| Albendazole | 1 | 2014 | 2 | 0.110 |
Why?
|
| Anthelmintics | 1 | 2014 | 4 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 10 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2018 | 890 | 0.110 |
Why?
|
| Infant | 1 | 2018 | 1014 | 0.110 |
Why?
|
| Conversion to Open Surgery | 1 | 2014 | 2 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2018 | 1149 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 68 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 10 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Premedication | 1 | 2013 | 5 | 0.110 |
Why?
|
| Colostomy | 1 | 2013 | 4 | 0.110 |
Why?
|
| Voice Disorders | 1 | 2013 | 3 | 0.110 |
Why?
|
| Rectal Diseases | 1 | 2013 | 10 | 0.110 |
Why?
|
| Ileostomy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2013 | 10 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 2013 | 9 | 0.110 |
Why?
|
| Iran | 1 | 2013 | 15 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2013 | 63 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2013 | 50 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 47 | 0.100 |
Why?
|
| Child | 2 | 2018 | 2253 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 818 | 0.100 |
Why?
|
| Administration, Rectal | 1 | 2013 | 5 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 20 | 0.100 |
Why?
|
| Shivering | 1 | 2013 | 1 | 0.100 |
Why?
|
| Morphine | 1 | 2013 | 29 | 0.100 |
Why?
|
| Time Factors | 2 | 2014 | 1593 | 0.100 |
Why?
|
| Anesthetics | 1 | 2013 | 9 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 5 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2013 | 30 | 0.100 |
Why?
|
| Choledocholithiasis | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2012 | 3 | 0.100 |
Why?
|
| Amputation | 2 | 2013 | 42 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2013 | 166 | 0.100 |
Why?
|
| Feeding and Eating Disorders | 1 | 2012 | 15 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 372 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 113 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2013 | 64 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2012 | 65 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2010 | 60 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 26 | 0.090 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2010 | 4 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 39 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2010 | 288 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 75 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 153 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 345 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2009 | 58 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 521 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 406 | 0.070 |
Why?
|
| Tracheal Diseases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Ossification, Heterotopic | 1 | 2006 | 6 | 0.060 |
Why?
|
| Cartilage Diseases | 1 | 2006 | 5 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2019 | 237 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 27 | 0.060 |
Why?
|
| Debridement | 2 | 2013 | 10 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 36 | 0.040 |
Why?
|
| Drainage | 2 | 2013 | 45 | 0.040 |
Why?
|
| Ischemia | 2 | 2013 | 84 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 93 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2018 | 7 | 0.040 |
Why?
|
| Burnout, Professional | 1 | 2018 | 21 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 41 | 0.040 |
Why?
|
| Contraindications, Procedure | 1 | 2017 | 1 | 0.030 |
Why?
|
| Benchmarking | 1 | 2016 | 33 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 210 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 59 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 523 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 2015 | 1 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2015 | 29 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 111 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 22 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 407 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 9 | 0.030 |
Why?
|
| Voice Quality | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cause of Death | 1 | 2014 | 73 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 65 | 0.030 |
Why?
|
| Anal Canal | 1 | 2013 | 19 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 465 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 68 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 50 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 125 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 238 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 733 | 0.030 |
Why?
|
| Heel | 1 | 2013 | 3 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 390 | 0.030 |
Why?
|
| Diabetic Neuropathies | 1 | 2013 | 14 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2013 | 14 | 0.030 |
Why?
|
| Vascular Grafting | 1 | 2013 | 11 | 0.030 |
Why?
|
| Colon | 1 | 2013 | 121 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2013 | 23 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 478 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2013 | 66 | 0.020 |
Why?
|
| Cholangiography | 1 | 2012 | 7 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 21 | 0.020 |
Why?
|
| Wound Healing | 1 | 2013 | 125 | 0.020 |
Why?
|
| Polysomnography | 1 | 2012 | 44 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 330 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 24 | 0.020 |
Why?
|
| Receptors, Thyrotropin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Laser Capture Microdissection | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2010 | 32 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2010 | 103 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 50 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 269 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 28 | 0.020 |
Why?
|
| Foot | 1 | 2008 | 23 | 0.020 |
Why?
|